• Perma-Fix Environmental Services announced in August 2026 that it had formed a Partnership with Mirion Technologies under the SBA’s Mentor-Protégé Program to jointly pursue U.S. Department of Energy nuclear cleanup and environmental remediation work.
• The collaboration pairs Perma-Fix’s nuclear waste treatment and remediation capabilities with Mirion’s radiation detection and measurement technologies, potentially enhancing their competitiveness in complex, long-duration federal cleanup projects.
• Next, we’ll examine how this Mentor-Protégé Partnership, centered on advanced waste characterization and radiological measurement, may influence Mirion’s existing investment narrative.

The latest GPUs need a type of rare earth metal called Dysprosium and there are only 28 companies in the world exploring or producing it. Find the list for free.

Mirion Technologies Investment Narrative Recap

To own Mirion, you need to believe its radiation detection and monitoring technologies can compound value across nuclear, medical, and research markets, even with modest margins and concentrated end markets. The Perma-Fix Mentor Protégé Partnership aligns with Mirion’s role in complex nuclear projects but does not materially change the near term focus on execution, integration of past acquisitions, and lifting return on equity, nor the key risk around a structurally uneven long term nuclear demand profile.

Among Mirion’s recent announcements, the reaffirmed 2026 revenue growth guidance of about 22 to 24 percent stands out beside the Perma-Fix news, as it underlines management’s confidence in the existing backlog and project pipeline. The Perma-Fix collaboration fits into that backdrop as an incremental way to deepen Mirion’s presence in long duration nuclear cleanup work, but investors still need to watch whether hardware heavy projects can translate into sustained margin improvement and higher quality, recurring earnings over time.

Yet beneath the promise of deeper DOE work, investors should be aware that Mirion’s heavy exposure to nuclear markets could...

Mirion Technologies' narrative projects $1.4 billion revenue and $213.4 million earnings by 2029. This requires 10.5% yearly revenue growth and an $188.9 million earnings increase from $24.5 million today.

Uncover how Mirion Technologies' forecasts yield a $24.80 fair value, a 56% upside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community currently place Mirion’s fair value between US$14.61 and US$24.80, highlighting a wide band of expectations. Against that backdrop, the company’s dependence on a concentrated nuclear end market raises important questions about how resilient those valuations might prove over time, which readers should explore through multiple viewpoints.

Explore 4 other fair value estimates on Mirion Technologies - why the stock might be worth 8% less than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Mirion Technologies research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Mirion Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Mirion Technologies' overall financial health at a glance.

Searching For A Fresh Perspective?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
• The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.